Author: Fiona Craig
-
SpaceX Listing Pushes Elon Musk Beyond the Trillion-Dollar Mark
Elon Musk has become the world’s first trillionaire following the record-breaking initial public offering of SpaceX (NASDAQ:SPCX), further cementing his status as one of the most influential and closely watched business figures of the modern era. Few corporate leaders have achieved the level of public recognition enjoyed by Musk, whose blend of technological ambition, outspoken…
-
Oil Prices Extend Decline as Hopes for Iran De-Escalation Improve Market Sentiment
Oil prices moved lower for a second consecutive session on Friday after U.S. President Donald Trump abandoned plans for military action against Iran, easing concerns that the conflict could escalate further following a series of retaliatory attacks earlier in the week. By 0640 GMT, Brent crude futures had fallen $2.11, or 2.3%, to $88.27 per…
-
Gold Edges Higher as Markets Assess Prospects for U.S.-Iran Agreement
Gold prices posted modest gains on Friday, although the precious metal remained on course for a weekly loss as investors evaluated the possibility of a peace agreement between the United States and Iran and its potential impact on inflation expectations. By 05:29 ET (09:29 GMT), spot gold was up 0.2% at $4,220.27 per ounce. Despite…
-
SpaceX IPO Takes Centre Stage as Markets Weigh Iran Peace Prospects and Adobe Leadership Changes: Dow Jones, S&P, Nasdaq, Wall Street Futures
Futures Trade Cautiously Ahead of Key Market Events U.S. stock index futures were little changed on Friday as investors focused on two major developments: the highly anticipated stock market debut of SpaceX (NASDAQ:SPCX) and growing expectations that a diplomatic agreement could bring an end to the conflict between the United States and Iran. By 03:13…
-
SpaceX Secures $75 Billion Ahead of Historic Market Debut
SpaceX (NASDAQ:SPCX) has raised $75 billion (£56 billion) from institutional investors ahead of its public market debut on Friday, positioning the aerospace and artificial intelligence company for what is expected to be the largest stock market listing ever. According to a filing with the US Securities and Exchange Commission, the company sold $75 billion worth…
-
American Fusion Expands Texatron Fusion Engine Patent Portfolio and Advances 5MW Development Program (AMFN)
The company added a new patent application while reporting progress on regulatory reviews, testing infrastructure, and development of its pre-production fusion energy system. Key Investor Takeaways Why AMFN Stock Is In Focus American Fusion announced the filing of U.S. Patent Application No. 19/701,742, covering a fusion system architecture designed to support plasma confinement, pulsed energy…
-
Vivos Receives Washington Radioactive Materials License for IsoPet Manufacturing, Enabling Domestic Production Expansion (RDGL)
The approval allows Vivos to begin in-house manufacturing of IsoPet and supports broader commercialization of its veterinary cancer treatment platform. Key Investor Takeaways Why RDGL Stock Is In Focus Vivos announced that it has obtained a Washington State Radioactive Materials License authorizing the manufacture of IsoPet®, the company’s Yttrium-90-based cancer treatment for companion animals and…
-
HWAL Expands Advisory Board With Media and Finance Veteran Jamie Shortill Amid Growth Strategy (HWAL)
The appointment adds investment banking, media, and sports industry expertise as HWAL pursues expansion across entertainment, digital assets, AI, blockchain, and fintech markets. Key Investor Takeaways Why HWAL Stock Is In Focus HWAL announced the appointment of Jamie Shortill to its Board of Advisors as the company prepares for what it describes as global growth…
-
Eco Innovation Group Advances SAF Test Plant Development as EPCM Partner Selection Nears (ECOX)
The company is approaching a key engineering milestone that could move its sustainable aviation fuel technology closer to certification and commercial deployment. Key Investor Takeaways Why ECOX Stock Is In Focus Eco Innovation Group announced that it is evaluating a shortlist of engineering firms to provide Engineering, Procurement and Construction Management services for its planned…
-
BeOne Highlights Phase 3 BRUKINSA Data in Older CLL Patients and Advances Leadership Position in BTK Inhibitors (ONC)
New data presented at EHA 2026 showed durable long-term outcomes for BRUKINSA in patients aged 80 and older, while additional real-world analyses reinforced its competitive position in chronic lymphocytic leukemia. Key Investor Takeaways Why ONC Stock Is In Focus BeOne unveiled one of the largest datasets to date evaluating first-line BRUKINSA treatment in patients aged…